Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization traded on NASDAQ under the symbol CDMO, disclosed on February 10, 2025, the introduction of its fresh corporate website. With a focus on enhancing customer experience, the website, accessible at www.avidbio.com, amalgamates Avid's refined brand narrative and visual elements with enhanced functionality and navigation. The company aims to serve biotechnology and pharmaceutical firms by providing top-notch development and manufacturing services.